注射器、针头和导尿管市场：规模、细分市场、份额、法规、报销、程序和到 2033 年的预测

注射器和针头是用来将液体注入体内或从体内抽出液体的器械。 注射器由连接到空心管的针头和滑动柱塞组成，有助于吸入和挤出液体。 注射器和针头用于给患者註射液体和从患者体内抽取液体。 导尿管用于治疗尿失禁、尿滞留和其他泌尿系统疾病的患者。 导尿管是一种从膀胱排出尿液的柔性管。 导尿管包括留置（福利）导尿管、间歇（短期）导尿管和外部（保险套）导尿管。

本报告详细研究了全球注射器、针头和导尿管市场，包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势等。

目录

注射器、针头、导尿管及目前市场竞争状况

• 对主要产业趋势的见解
• 2015 年至 2033 年註射器、针头及导尿管各细分市场的市场总收入及市场前景
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域与国家见解

• 注射器、针头和导尿管市场的 SWOT 分析
• 注射器、针头和导尿管市场的竞争动态见解和趋势
• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技的监管状况

Abstract

Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Hospital Supplies therapeutic area.

The model discusses the effect of COVID -19 on the Syringes, Needles, and Urinary Catheters market for the year 2020 and beyond. Syringe and Needles are devices used to inject fluids into or withdraw fluids from the body. A Syringe consist of a needle which is attached to a hollow tube with a sliding plunger that can help to intake or push down the fluid. Syringes and Needles are used for administration of several fluids and drawing fluids in the patients. Urinary catheters are used to treat patients with urinary incontinence, urinary retention, or other urological disorders. A urinary catheter is a flexible tube which is used to drain urine from the bladder. Urinary catheters include indwelling (Foley) catheter, intermittent (short term) catheter, and external (condom) catheter.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Syringes, Needles, and Urinary Catheters and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Syringes, Needles, and Urinary Catheters market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Syringes, Needles, and Urinary Catheters market.
• Competitive dynamics insights and trends provided for Syringes, Needles, and Urinary Catheters market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Becton Dickinson and Co, Equashield LLC, Avanos Medical Inc, Cardinal Health Inc, Novo Nordisk AS, Teleflex Inc, Coloplast Corp, Stryker Corp, Medline Industries LP, Hollister Inc, Bioderm Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Syringes, Needles, and Urinary Catheters marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Syringes, Needles, and Urinary Catheters.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Syringes, Needles, and Urinary Catheters market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Syringes, Needles, and Urinary Catheters market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Syringes, Needles, and Urinary Catheters market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable